drugset / Trial / NCT03245996

The Impact of Heart Rate on Central Blood Pressure in Sick Sinus Syndrome Patients With a Permanent Cardiac Pacemaker

NCT03245996

Phase 4 Completed 27 enrolled Tartu University Hospital
NaSingle-groupSingle-blindBasic science

Summary

This study is divided into two parts: * The first part evaluates the acute effect of non-pharmacological heart rate change on central hemodynamic parameters noninvasively in sick sinus syndrome patients with a permanent cardiac pacemaker * The second part evaluates the acute effects of atenolol, nebivolol and ivabradine on central hemodynamic parameters noninvasively in sick sinus syndrome patients with a permanent cardiac pacemaker at different pacing rate levels

Timeline

Start
2015-06
Primary completion
2016-09
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Atenolol Other / unclassified 50 mg Oral
Subject Atenolol Other / unclassified 100 mg Oral
Subject Ivabradine Small molecule 5 mg Oral
Subject Ivabradine Small molecule 7.5 mg Oral
Subject Nebivolol Other / unclassified 5 mg Oral

Indications

No indication recorded.